You are here: Home » Archives for board of directors

LeddarTech Appoints Chris Stewart as Chief Financial Officer

QUEBEC CITY, Canada, Nov. 15, 2023 (GLOBE NEWSWIRE) — LeddarTech , an automotive software company that provides patented disruptive low–level sensor fusion and perception software technology for ADAS and AD, proudly announces the appointment of Mr. Chris Stewart as Chief Financial Officer ("CFO").

As CFO at LeddarTech, Mr. Stewart will be instrumental in supporting LeddarTech in completing its recently announced business combination with Prospector Capital Corp. and transitioning to a publicly traded company.

Mr. Stewart has over 20 years of financial management experience at companies ranging from startups to large public companies. Mr. Stewart previously served as the Chief Financial Officer of Bionano Genomics Inc. (NASDAQ: BNGO) from September 2020 until joining LeddarTech in November 2023, Head of Maxwell Ultracapacitors at Tesla Inc. (NASDAQ: TSLA) from May 2019 to July 2020 and as Vice President of Finance and Information Technology at Maxwell Technologies Inc., a public energy storage company, from July 2015 to May 2019, at which time the company was acquired by Tesla. In addition, Mr. Stewart held multiple leadership roles, including Vice President of Finance at Entropic Communications and Chief Financial Officer of V–ENABLE Inc. (currently GroundTruth), a leader in targeted mobile advertising.

Mr. Stewart received his B.S. in Business Administration from the University of Southern California and his M.S. in Industrial Administration from Carnegie Mellon University.

"I am thrilled to join such a visionary company and work alongside LeddarTech's employees at such an exciting time," stated Mr. Stewart. "I eagerly anticipate forging formidable alliances at all levels, including with LeddarTech's shareholders and its board of directors and leadership team, and support LeddarTech as it works toward completing its business combination and operating as a publicly traded company. I am extremely energized by LeddarTech's accomplishments and look forward to helping it realize all of its potential."

Mr. Charles Boulanger, CEO of LeddarTech, commented: "I am very pleased that Chris has joined the executive team of LeddarTech as Chief Financial Officer. As an accomplished financial executive with extensive experience in leading and optimizing the financial operations of various organizations, Chris has a strong track record of managing and transforming financial functions to drive profitability and growth. Chris's skill set perfectly aligns with LeddarTech's strategic goals."

LeddarTech Inc. ("LeddarTech") and Prospector Capital Corp. ("Prospector") (NASDAQ: PRSR, PRSRU, PRSRW), a Cayman Islands exempted company led by former Qualcomm President Derek Aberle and chaired by former Qualcomm Vice Chairman Steve Altman, are party to a definitive business combination agreement that, upon completion of the business combination, would result in LeddarTech becoming a publicly listed company. Upon closing of the transaction, which is expected during the fourth quarter of 2023, the combined company formed through the business combination, LeddarTech Holdings Inc. ("Newco"), is expected to be listed on NASDAQ under the ticker symbol "LDTC."

About LeddarTech

A global software company founded in 2007 and headquartered in Quebec City with additional R&D centers in Montreal, Toronto and Tel Aviv, Israel, LeddarTech develops and provides comprehensive perception software solutions that enable the deployment of ADAS and autonomous driving (AD) applications. LeddarTech's automotive–grade software applies advanced AI and computer vision algorithms to generate accurate 3D models of the environment, allowing for better decision making and safer navigation. This high–performance, scalable, cost–effective technology is available to OEMs and Tier 1–2 suppliers to efficiently implement automotive and off–road vehicle ADAS solutions.

LeddarTech is responsible for several remote–sensing innovations, with over 150 patent applications (80 granted) that enhance ADAS and AD capabilities. Better awareness around the vehicle is critical in making global mobility safer, more efficient, sustainable and affordable: this is what drives LeddarTech to seek to become the most widely adopted sensor fusion and perception software solution.

Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook and YouTube.

About Prospector Capital Corp.

Prospector is a special–purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses with a focus on companies with advanced and highly differentiated solutions for the technology sector. The company is led by a team of experienced investors and executives focused on identifying and investing in high–growth companies with strong management teams and attractive market opportunities. Prospector's securities are traded on NASDAQ under the ticker symbols "PRSR," "PRSRU" and "PRSRW."

Important Information About the Proposed Transaction and Where to Find It

In connection with the proposed business combination, Prospector, LeddarTech and Newco will prepare and will file with the SEC the registration statement on Form F–4 (the "Registration Statement"), and Prospector will mail the proxy statement/prospectus contained within the Registration Statement to its shareholders and file other documents regarding the business combination with the SEC. This press release is not a substitute for any proxy statement, registration statement, proxy statement/prospectus or other documents Prospector or Newco may file with the SEC in connection with the business combination. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ CAREFULLY AND IN THEIR ENTIRETY THE REGISTRATION STATEMENT WHEN IT BECOMES AVAILABLE, ANY AMENDMENTS OR SUPPLEMENTS TO THE REGISTRATION STATEMENT AND OTHER DOCUMENTS FILED BY PROSPECTOR OR NEWCO WITH THE SEC IN CONNECTION WITH THE BUSINESS COMBINATION, BECAUSE THESE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders will be able to obtain free copies of the Registration Statement and other documents filed with the SEC by Prospector or Newco through the website maintained by the SEC at www.sec.gov.

Forward–Looking Statements

Certain statements contained in this press release may be considered forward–looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Exchange Act (which forward–looking statements shall also include forward–looking statements and forward–looking information within the meaning of applicable Canadian securities laws), including, but not limited to, statements regarding the business combination involving Prospector, LeddarTech and Newco, the ability to consummate the business combination and the timing thereof, the anticipated benefits from the business combination, the closing of the private placement financing and expected proceeds therefrom and statements relating to Newco's anticipated strategy, future operations, prospects, objectives and financial projections and other financial metrics. Forward–looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "anticipate," "plan," "likely," "believe," "estimate," "project," "intend" and other similar expressions among others. Statements that are not historical facts are forward–looking statements. Forward–looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward–looking statement as a result of various factors, including, without limitation: (i) the risk that the conditions to the closing of the business combination are not satisfied, including the failure to timely or at all obtain shareholder approval for the business combination or the failure to timely or at all obtain any required regulatory clearances, including of the Superior Court of Justice of Qubec; (ii) uncertainties as to the timing of the consummation of the business combination and the ability of each of Prospector, LeddarTech and Newco to consummate the business combination; (iii) the possibility that other anticipated benefits of the business combination will not be realized, and the anticipated tax treatment of the business combination; (iv) the occurrence of any event that could give rise to termination of the business combination; (v) the risk that shareholder litigation in connection with the business combination or other settlements or investigations may affect the timing or occurrence of the business combination or result in significant costs of defense, indemnification and liability; (vi) changes in general economic and/or industry–specific conditions; (vii) possible disruptions from the business combination that could harm LeddarTech's business; (viii) the ability of LeddarTech to retain, attract and hire key personnel; (ix) potential adverse reactions or changes to relationships with customers, employees, suppliers or other parties resulting from the announcement or completion of the business combination; (x) potential business uncertainty, including changes to existing business relationships, during the pendency of the business combination that could affect LeddarTech's financial performance; (xi) legislative, regulatory and economic developments; (xii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism, outbreak of war or hostilities and any epidemic, pandemic or disease outbreak (including COVID–19), as well as management's response to any of the aforementioned factors; (xiii) access to capital and financing and LeddarTech's ability to maintain compliance with debt covenants; and (xiv) other risk factors as detailed from time to time in Prospector's reports filed with the SEC, including Prospector's Annual Report on Form 10–K, periodic Quarterly Reports on Form 10–Q, periodic Current Reports on Form 8–K and other documents filed with the SEC, as well as the risk factors to be contained in the Registration Statement. The foregoing list of important factors is not exhaustive. Neither Prospector nor LeddarTech can give any assurance that the conditions to the business combination will be satisfied. Except as required by applicable law, neither Prospector nor LeddarTech undertakes any obligation to revise or update any forward–looking statement, or to make any other forward–looking statements, whether as a result of new information, future events or otherwise.

No Offer or Solicitation

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities of Prospector or Newco, a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended (the "Securities Act").

Participants in Solicitation

Prospector, LeddarTech and Newco, and certain of their respective directors, executive officers and employees, may be deemed to be participants in the solicitation of proxies in connection with the business combination. Information about the directors and executive officers of Prospector can be found in the Annual Report on Form 10–K for the fiscal year ended December 31, 2022, which was filed with the SEC on March 31, 2023. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of proxies in connection with the business combination, including a description of their direct or indirect interests, by security holdings or otherwise, will be set forth in the Registration Statement and other relevant materials when they are filed with the SEC. These documents can be obtained free of charge from the source indicated above.

Contact:
Daniel Aitken, Vice–President, Global Marketing, Communications and Investor Relations, LeddarTech Inc. Tel.: + 1–418–653–9000 ext. 232 daniel.aitken@LeddarTech.com

Leddar, LeddarTech, LeddarVision, LeddarSP, VAYADrive, VayaVision and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.


GLOBENEWSWIRE (Distribution ID 8979411)

Cellebrite Continues Global Growth with Appointment of First Global Chief Revenue Officer, Marcus Jewell

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 14, 2023 (GLOBE NEWSWIRE) — In a move that signals international momentum and market leadership, Cellebrite DI Ltd. (Nasdaq: CLBT), a global leader in Digital Intelligence (DI) solutions for the public and private sectors, announced today the appointment of Marcus Jewell as Global Chief Revenue Officer (CRO), effective November 15, 2023.

As CRO, Mr. Jewell will oversee worldwide sales for both the public and private sectors in support of the Company's strategic priorities. Together with the executive leadership team, Jewell will operate from Cellebrite's American headquarters in Tysons Corner, Virginia, and report directly into CEO Yossi Carmil.

"We are thrilled to welcome Marcus to the team and are confident his deep expertise will help further our leadership in the digital intelligence space, build our business in the private sector, and help customers harness the power of the cloud," says Carmil. "With a growing global customer base, a legacy for industry–leading end–to–end solutions, and a dedicated, talented team, we have an amazing opportunity before us to elevate the Cellebrite suite and brand. Marcus's hiring punctuates this moment and underscores our commitments to recruiting outstanding talent, scaling our business, and continuing to invent and advance our innovative technology in the field."

Mr. Jewell brings over 25 years' experience in senior–level sales and management to his new role, including an impressive five–year stint at Juniper Networks where he drove 50+% growth year–over–year and oversaw more than $5B in sales. He is skilled at leading high–performing global sales organizations, entering and managing international markets, and setting and achieving ambitious growth and profitability targets. In his roles at Mitel Networks and Brocade, he significantly increased market share, broadened customer bases and introduced the companies to new regions. Most recently, Mr. Jewell served as CRO at CSS LLC, the parent company of CloudKitchens, where he directed sales, marketing and customer success teams globally.

"I am excited to be joining Cellebrite and be part of this Company's relentless rise and growth as a force of public good and truth," said Marcus Jewell, incoming Global Chief Revenue Officer, Cellebrite. "As the pioneer in digital intelligence solutions, I am inspired by Cellebrite's 20+ years of innovation and I look forward to working with the team to accelerate revenue growth, enhance and expand the scope of our customer relationships in both public and private sectors by deliver outstanding training, service and support to the thousands of professionals who rely on our technology every day.”

About Cellebrite

Cellebrite's (NASDAQ: CLBT) mission is to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. We are a global leader in Digital Intelligence solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Trusted by thousands of leading agencies and companies worldwide, Cellebrite's Digital Intelligence platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. To learn more, visit us at www.cellebrite.com and https://investors.cellebrite.com.

Note: References to our website and the websites of third parties mentioned in this press release are inactive textual references only, and information contained therein or connected thereto is not incorporated into this press release.

Caution Regarding Forward–Looking Statements
This document includes "forward–looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward looking statements may be identified by the use of words such as "forecast," "intend," "seek," "target," "anticipate," "will," "appear," "approximate," "foresee," "might," "possible," "potential," "believe," "could," "predict," "should," "could," "continue," "expect," "estimate," "may," "plan," "outlook," "future" and "project" and other similar expressions that predict, project or indicate future events or trends or that are not statements of historical matters. Such forward–looking statements, include but are not limited to, the following: Marcus Jewell's potential contributions in leading Cellebrite's sales activities to fortify its leadership in digital forensic units, extend its reach into investigative units, build its business in the private sector and help its customers harness the power of the cloud; our plans to work together to build on our business momentum and accelerate our top–line growth over the long term; our commitment to further scale our business, drive profitable growth and enable customers in both the public and private sectors to effectively and efficiently address the challenges they face; and helping our teams drive strong revenue growth, enhance and expand the scope of our customer relationships and deliver outstanding training, service and support to the thousands of professionals who rely on our technology every day. Such forward–looking statements are based on current expectations that are subject to risks and uncertainties. A number of factors could cause actual results or outcomes to differ materially from those indicated by such forward–looking statements. These factors include, but are not limited to: Cellebrite's ability to keep pace with technological advances and evolving industry standards; Cellebrite's material dependence on the purchase, acceptance and use of its solutions by law enforcement and government agencies; real or perceived errors, failures, defects or bugs in Cellebrite's DI solutions; Cellebrite's failure to maintain the productivity of sales and marketing personnel, including relating to hiring, integrating and retaining personnel; intense competition in all of Cellebrite's markets; the inadvertent or deliberate misuse of Cellebrite's solutions; failure to manage its growth effectively; Cellebrite's ability to introduce new solutions and add–ons; its dependency on its customers renewing their subscriptions; the low volume of business Cellebrite conducts via e–commerce; risks associated with the use of artificial intelligence; the risk of requiring additional capital to support the growth of its business; risks associated with higher costs or unavailability of materials used to create its hardware product components; fluctuations in foreign currency exchange rates; lengthy sales cycle for some of Cellebrite's solutions; near term declines in new or renewed agreements; risks associated with inability to retain qualified personnel and senior management; the security of Cellebrite's operations and the integrity of its software solutions; risks associated with the negative publicity related to Cellebrite's business and use of its products; risks related to Cellebrite's intellectual property; risks associated with the regulatory constraints to which Cellebrite is subject; risks associated with different corporate governance requirements applicable to Israeli companies and risks associated with being a foreign private issuer and an emerging growth company; market volatility in the price of Cellebrite's shares; changing tax laws and regulations; risks associated with joint, ventures, partnerships and strategic initiatives; risks associated with Cellebrite's significant international operations; risks associated with Cellebrite's failure to comply with anti–corruption, trade compliance, anti–money–laundering and economic sanctions laws and regulations; risks relating to the adequacy of Cellebrite's existing systems, processes, policies, procedures, internal controls and personnel for Cellebrite's current and future operations and reporting needs; and other factors, risks and uncertainties set forth in the section titled "Risk Factors" in Cellebrite's annual report on Form 20–F filed with the SEC on April 27, 2023 and in other documents filed by Cellebrite with the U.S. Securities and Exchange Commission ("SEC"), which are available free of charge at www.sec.gov. You are cautioned not to place undue reliance upon any forward–looking statements, which speak only as of the date made, in this communication or elsewhere. Cellebrite undertakes no obligation to update its forward–looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

Media
Victor Cooper
Sr. Director, Corporate Communications + Content Operations
+1–404–804–5910
victor.cooper@cellebrite.com

Investors
Andrew Kramer
Vice President, Investor Relations
+1–973–206–7760
investors@cellebrite.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ab051ef0–fdaf–48b6–9cd9–ad1908d4cac4


GLOBENEWSWIRE (Distribution ID 8978812)

eXp Realty Taps Real Estate Veteran Bryon Ellington To Revolutionize Agent-Driven Learning

BELLINGHAM, Wash., Oct. 03, 2023 (GLOBE NEWSWIRE) — eXp Realty , "the most agent–centric real estate brokerage on the planet" and the core subsidiary of eXp World Holdings, Inc. (Nasdaq: EXPI), today announced the appointment of Bryon Ellington as Chief Learning Officer, responsible for developing custom, agent–driven training and coaching.

Ellington, a seasoned professional with more than 20 years of experience in real estate and coaching, brings a wealth of knowledge and expertise to eXp Realty. He will focus on developing agent–driven training at every level, setting a new standard for success in the real estate industry.

"Bryon's dedication to agent success aligns perfectly with our values, and he excels at driving growth and new revenue streams," said Glenn Sanford, Founder and CEO of eXp Realty. "Under his leadership, eXp Realty will become the leading brokerage in training, with a focus on delivering the best education and resources to help our agents excel. Throughout his career, Bryon has helped numerous agents achieve incredible accolades, increase productivity metrics and grow their businesses."

Ellington's passion is helping entrepreneurs in the real estate space build businesses beyond their dreams. "I am excited to join the eXp Realty team and contribute to its mission of empowering agents to reach their full potential," he said. "Whether you are a new agent or lead a massive team, with eXp you can continue to grow your business to exceed your goals."

Ellington's impressive tenure includes notable executive roles most recently as Chief Operating Officer and Chief Development Officer at Century 21. He also held positions at Keller Williams, as Chief Product Officer and Chief Operating Officer of the KW Worldwide International Franchising division. Additionally, he served as Chief Learning Officer, where his achievements earned him the distinction of winning the Training magazine T125 Top Training Companies award for four consecutive years and induction into the Hall of Fame.

Earlier in his career, at Anywhere (Realogy), he successfully created and led the training and coaching divisions for all their franchise brands and company–owned operations.

About eXp World Holdings, Inc.
eXp World Holdings, Inc. (Nasdaq: EXPI) is the holding company for eXp Realty , Virbela and SUCCESS Enterprises.

eXp Realty is the largest independent real estate company in the world with more than 89,000 agents in the United States, Canada, the United Kingdom, Australia, South Africa, India, Mexico, Portugal, France, Puerto Rico, Brazil, Italy, Hong Kong, Colombia, Spain, Israel, Panama, Germany, Dominican Republic, Greece, New Zealand, Chile, Poland and Dubai and continues to scale internationally. As a publicly traded company, eXp World Holdings provides real estate professionals the unique opportunity to earn equity awards for production goals and contributions to overall company growth. eXp World Holdings and its businesses offer a full suite of brokerage and real estate tech solutions, including its innovative residential and commercial brokerage model, professional services, collaborative tools and personal development. The cloud–based brokerage is powered by Virbela, an immersive 3D platform that is deeply social and collaborative, enabling agents to be more connected and productive. SUCCESS Enterprises, anchored by SUCCESS magazine and its related media properties, was established in 1897 and is a leading personal and professional development brand and publication.

For more information, visit https://expworldholdings.com.

Safe Harbor Statement

The statements contained herein may include statements of future expectations and other forward–looking statements that are based on management's current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. Such forward–looking statements speak only as of the date hereof, and the company undertakes no obligation to revise or update them. Such statements are not guarantees of future performance. Important factors that may cause actual results to differ materially and adversely from those expressed in forward–looking statements include changes in business or other market conditions; the difficulty of keeping expense growth at modest levels while increasing revenues; and other risks detailed from time to time in the company's Securities and Exchange Commission filings, including but not limited to the most recently filed Quarterly Report on Form 10–Q and Annual Report on Form 10–K.

Media Relations Contact:

eXp World Holdings, Inc.

mediarelations@expworldholdings.com

Investor Relations Contact:

Denise Garcia

investors@expworldholdings.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ba1c70f4–dd70–43ad–b440–7b1197f7200d


GLOBENEWSWIRE (Distribution ID 8942516)

A Quantexa nomeia personalidades conhecidas do setor para o seu Conselho Consultivo para acelerar os planos de crescimento

LONDRES, Sept. 25, 2023 (GLOBE NEWSWIRE) — A Quantexa, lder global em solues de Inteligncia de deciso (DI) para os setores pblico e privado, anunciou hoje que nomeou trs personalidades do setor para o seu Conselho Consultivo. Estas contrataes incluem Ralph Schlosstein, antigo diretor executivo da Evercore e antigo presidente da BlackRock, Matthew Gould, antigo diretor executivo da NHSX, e Sir Jeremy Fleming, antigo diretor do GCHQ. Estes lderes de renome trazem para a Quantexa uma vasta experincia em finanas, cuidados de sade e segurana nacional.

A expanso do Conselho Consultivo da Quantexa ocorre num momento crucial para a organizao, aps a concluso de uma ronda de financiamento da Srie E de 129 milhes de dlares, liderada pelo GIC, em que a Quantexa se juntou a um grupo de elite de empresas tecnolgicas do Reino Unido que alcanaram o estatuto de unicrnio. Foi tambm anunciado este ano que a Quantexa ir investir mais de 155 milhes de dlares na indstria global de IA durante os prximos trs anos para ajudar os clientes a avanar na utilizao da IA para proteger, otimizar e expandir as suas organizaes. At 2027, o investimento global total da Quantexa em IA atingir mais de 250 milhes de dlares.

Ralph Schlosstein, antigo Diretor Executivo da Evercore e antigo Presidente da BlackRock, traz dcadas de experincia em banca de investimento para o Conselho Consultivo da Quantexa. A sua carreira de sucesso inclui o desempenho de um papel estratgico ao ajudar a maior empresa de gesto de ativos do mundo a tornar–se pblica. A perspiccia financeira de Ralph desempenhar um papel fundamental na definio das iniciativas estratgicas da empresa.

Matthew Gould, ex–diretor executivo da NHSX, junta–se ao Conselho Consultivo da Quantexa, depois de ter sido embaixador britnico em Israel entre 2010 e 2015, onde Gould ajudou a lanar o UK–Israel Technologies Hub – uma iniciativa gerida em Telavive para criar parcerias tecnolgicas entre empresas britnicas e israelitas. Mais recentemente, Matthew aproveitou a sua vasta experincia em cuidados de sade para desempenhar um papel fundamental no aconselhamento ao NHS sobre iniciativas durante a pandemia de Covid–19. Na NHSX, Gould foi responsvel por aproveitar o poder dos dados e da tecnologia para melhorar a prestao de cuidados de sade. Os conhecimentos profundos de Matthew ajudaro a Quantexa a identificar as economias e os setores que merecem uma ateno estratgica e a tomar decises sobre a estratgia comercial.

Sir Jeremy Fleming, antigo diretor do GCHQ e antigo diretor–adjunto do MI5, junta–se ao Conselho Consultivo com mais de 30 anos de experincia em servios secretos e tecnologia. A sua vasta experincia inclui o desenvolvimento do National Cyber Security Centre, onde se esforou por tornar o Reino Unido o local mais seguro para viver e fazer negcios online. Apaixonado por tornar mais transparente a utilizao da tecnologia na administrao pblica, Sir Fleming reforar as capacidades da Quantexa para fazer face s ameaas e oportunidades emergentes.

“Temos o prazer de acolher Ralph Schlosstein, Matthew Gould e Sir Jeremy Fleming no nosso Conselho Consultivo”. afirmou Vishal Marria, Diretor Executivo da Quantexa. “O seu conhecimento tcnico coletivo em finanas, sade e segurana nacional ser fundamental para continuarmos a desenvolver solues de inteligncia de deciso inovadoras que atendam s necessidades em evoluo do mercado.”

“A tecnologia ativada por IA da Quantexa permite que os seus clientes protejam, otimizem e desenvolvam as suas organizaes com eficincia e transparncia” afirmou Ralph Schlosstein, antigo diretor executivo da Evercore e antigo presidente da BlackRock. "Acredito que a Quantexa est bem posicionada para aproveitar as oportunidades que se avizinham e aumentar a sua quota na categoria emergente de Inteligncia de Deciso. Estou ansioso por apoiar a equipa executiva no seu trabalho de acelerao da sua estratgia de crescimento orgnico e inorgnico."

” uma altura muito interessante para eu me juntar ao Conselho Consultivo da Quantexa, nesta fase crtica de crescimento da empresa”,disse Matthew Gould. “A abordagem inovadora da Quantexa para ajudar os clientes dos setores pblico e privado a fazer dos dados a sua utilidade mais valiosa est a revolucionar a tomada de decises em vrios setores. Estou ansioso por trabalhar com a talentosa equipa da Quantexa para interligar dados e obter melhores resultados para as organizaes.”

Sir Jeremy Fleming, antigo diretor do GCHQ, comentou “Estou entusiasmado por fazer parte de uma empresa na vanguarda da inovao da IA. Estou ansioso por combinar a minha experincia com as impressionantes capacidades da Quantexa, que continuaro a moldar a forma como os seus clientes utilizam os dados para proteger as empresas e os cidados.”

Com a ajuda do seu Conselho Consultivo, a Quantexa continua dedicada em capacitar as organizaes a tomarem decises operacionais fiveis atravs de solues inovadoras de Inteligncia de Deciso. Para mais informaes sobre a equipa de liderana da Quantexa, clique aqui.

Sobre a Quantexa"

A Quantexa uma empresa global de software de dados e anlise, pioneira na Inteligncia de Deciso que permite s organizaes tomar decises operacionais fiveis, tornando os dados significativos. Utilizando os mais recentes avanos em big data e IA, a Decision Intelligence Platform da Quantexa revela riscos ocultos e novas oportunidades, fornecendo uma viso contextual e conectada de dados internos e externos num nico local. Resolve os maiores desafios em toda a gesto de dados, KYC, informaes do cliente, crime financeiro, risco, fraude e segurana, ao longo do ciclo de vida do cliente.

A Decision Intelligence Platform da Quantexa melhora o desempenho operacional com mais de 90% de preciso e uma resoluo de modelos analticos 60 vezes mais rpida do que as abordagens tradicionais. Fundada em 2016, a Quantexa tem atualmente mais de 650 funcionrios e milhares de utilizadores que trabalham com milhares de milhes de transaes e pontos de informao em todo o mundo. A empresa tem escritrios em Londres, Dublin, Nova Iorque, Boston, Washington DC, Toronto, Emirados rabes Unidos, Mlaga, Amesterdo, Luxemburgo, Bruxelas, Melbourne, Sydney e Singapura. Para mais informaes, siga–nos no LinkedIn.

Contacto para os meios de comunicao social:
C: Stephanie Crisp, Diretora–Adjuta e Estratega de Meios de Comunicao, Fight or Flight""
E: Quantexa@fightflight.co.uk""
"
C: Adam Jaffe, VPS de Marketing Empresarial""
T: +1 609 502 6889""
E: adamjaffe@quantexa.com""


GLOBENEWSWIRE (Distribution ID 1000841125)

Quantexa nomme de grands noms du secteur à son comité consultatif pour accélérer ses plans de croissance

LONDRES, 25 sept. 2023 (GLOBE NEWSWIRE) — Quantexa, leader mondial des solutions d'intelligence dcisionnelle pour les secteurs priv et public, a annonc aujourd'hui la nomination de trois grands noms du secteur au sein de son comit consultatif. Il s'agit de Ralph Schlosstein, ancien PDG d'Evercore et ancien prsident de BlackRock, Matthew Gould, ancien PDG de NHSX, et Sir Jeremy Fleming, ancien directeur du GCHQ. Ces leaders de renom apporteront Quantexa leur prcieuse exprience dans les domaines de la finance, des soins de sant et de la scurit nationale.

L'largissement du comit consultatif de Quantexa survient un moment crucial pour la socit, puisqu'elle a achev un cycle de financement de srie E de 129 millions de dollars, men par GIC, au cours duquel Quantexa a rejoint un groupe privilgi d'entreprises technologiques britanniques sur le point de devenir des licornes. Il a galement t annonc cette anne que Quantexa investira plus de 155 millions de dollars dans le secteur mondial de l'IA au cours des trois prochaines annes afin d'aider les clients promouvoir l'utilisation de l'IA pour protger, optimiser et dvelopper leurs organisations. D'ici 2027, l'investissement mondial total de Quantexa dans l'IA atteindra plus de 250 millions de dollars.

Ralph Schlosstein, ancien PDG d'Evercore et ancien prsident de BlackRock, apportera au comit consultatif de Quantexa ses dcennies d'exprience dans le domaine des investissements bancaires. Au cours de sa carrire, il a notamment jou un rle stratgique dans l'introduction en bourse de la plus grande socit de gestion d'actifs au monde. La perspicacit financire de Ralph Schlosstein sera dterminante pour l'laboration des initiatives stratgiques de l'entreprise.

Matthew Gould, ancien PDG de NHSX, rejoint le comit consultatif de Quantexa aprs avoir t ambassadeur britannique en Isral entre 2010 et 2015, o il a contribu au lancement du UK–Israel Technologies Hub, une initiative mene Tel–Aviv visant forger des partenariats technologiques entre des entreprises britanniques et israliennes. Plus rcemment, Matthew Gould a mis profit sa vaste exprience dans le domaine des soins de sant pour conseiller le NHS sur les initiatives prendre pendant la pandmie de Covid–19. Chez NHSX, Matthew Gould a eu pour mission d'exploiter la puissance des donnes et de la technologie pour amliorer la prestation des soins de sant. Sa grande exprience aidera Quantexa identifier les marchs et les secteurs d'activit privilgier, ainsi qu' prendre des dcisions en matire de stratgie commerciale.

Sir Jeremy Fleming, ancien directeur du GCHQ et ancien directeur adjoint du MI5, rejoint le comit consultatif, fort de plus de 30 ans d'exprience dans le domaine du renseignement et de la technologie. Sa vaste exprience comprend notamment le dveloppement du Centre national de cyberscurit, o il s'est donn pour mission de faire du Royaume–Uni le pays le plus sr o vivre et entreprendre en ligne. Ayant c"ur de rendre l'utilisation des technologies au sein des gouvernements plus transparente, Sir Fleming aidera Quantexa tirer profit des nouvelles opportunits et faire face aux menaces mergentes.

Nous sommes heureux d'accueillir Ralph Schlosstein, Matthew Gould et Sir Jeremy Fleming au sein de notre comit consultatif , a dclar Vishal Marria, PDG de Quantexa. Leur expertise conjointe dans les domaines de la finance, des soins de sant et de la scurit nationale sera un atout inestimable pour continuer laborer des solutions de pointe en matire d'intelligence dcisionnelle qui rpondent aux besoins du march en constante volution.

La technologie de Quantexa base sur l'IA permet ses clients de protger, d'optimiser et de dvelopper leurs organisations avec efficacit et transparence , a dclar Ralph Schlosstein, ancien PDG d'Evercore et ancien prsident de BlackRock. Je pense que Quantexa a toutes les cartes en main pour saisir les opportunits venir et accrotre sa prsence dans la catgorie mergente qu'est l'intelligence dcisionnelle. Je suis ravi de pouvoir aider l'quipe de direction acclrer sa stratgie de croissance organique et inorganique.

C'est une tape passionnante pour moi que de rejoindre le comit consultatif de Quantexa, ce stade si dcisif de la croissance de l'entreprise , a ajout Matthew Gould. L'approche innovante de Quantexa, qui consiste aider les clients des secteurs priv et public faire des donnes leur principal outil, rvolutionnera la prise de dcision dans de nombreux secteurs d'activit. Je me rjouis de travailler avec l'quipe talentueuse de Quantexa pour interconnecter les donnes et aider les organisations obtenir de meilleurs rsultats.

Sir Jeremy Fleming, ancien directeur du GCHQ, a dclar : Je suis ravi de faire partie d'une entreprise qui est la pointe de l'innovation dans le domaine de l'IA. Je suis impatient de mettre mon exprience au service des capacits exceptionnelles de Quantexa, qui continueront faonner la manire dont ses clients utilisent les donnes pour protger les entreprises et les citoyens .

Avec le soutien de son comit consultatif, Quantexa continuera d'aider les organisations prendre des dcisions oprationnelles fiables grce des solutions innovantes d'intelligence dcisionnelle. Pour en savoir plus sur l'quipe de direction de Quantexa, cliquez ici.

propos de Quantexa"

Pionnire de l'intelligence dcisionnelle, Quantexa est une socit mondiale de logiciels de donnes et d'analyse qui permet aux organisations de prendre des dcisions oprationnelles fiables en rendant les donnes significatives. En utilisant les dernires avances en matire de Big Data et d'IA, la plateforme d'intelligence dcisionnelle de Quantexa rvle les risques cachs et les nouvelles opportunits en fournissant une vision contextuelle et connecte des donnes internes et externes en un seul endroit. Elle rsout des dfis majeurs dans les domaines de la gestion des donnes, de la connaissance du client, de l'intelligence client, de la criminalit financire, des risques, de la fraude et de la scurit, tout au long du cycle de vie client.

La plateforme d'intelligence dcisionnelle de Quantexa amliore la performance oprationnelle avec une prcision accrue de plus de 90 % et une rsolution du modle analytique 60 fois plus rapide que les approches traditionnelles. Fonde en 2016, Quantexa compte aujourd'hui plus de 650 collaborateurs et des milliers d'utilisateurs travaillant avec des milliards de transactions et de points de donnes travers le monde. Les bureaux de la socit sont situs Londres, Dublin, New York, Boston, Washington DC, Toronto, EAU, Malaga, Amsterdam, Luxembourg, Bruxelles, Melbourne, Sydney et Singapour. Pour en savoir plus, suivez–nous sur LinkedIn.

Contact presse :
Contact : Stephanie Crisp, directrice associe et stratge mdia, Fight or Flight""
E–mail : Quantexa@fightflight.co.uk""
"
Contact : Adam Jaffe, vice–prsident snior du marketing d'entreprise
Tlphone : +1 609 502 6889""
E–mail : adamjaffe@quantexa.com""


GLOBENEWSWIRE (Distribution ID 1000841125)

Quantexa ernennt zur Beschleunigung von Wachstumsplänen führende Persönlichkeiten der Branche in seinen Beirat

LONDON, Sept. 25, 2023 (GLOBE NEWSWIRE) — Quantexa, der weltweit fhrende Anbieter von Decision Intelligence (DI)–Lsungen fr den privaten und ffentlichen Sektor, hat heute bekanntgegeben, dass er drei Koryphen der Branche in seinen Beirat berufen hat. Zu diesen Neuzugngen gehren Ralph Schlosstein, ehemaliger CEO von Evercore und ehemaliger President von BlackRock, Matthew Gould, ehemaliger CEO von NHSX, und Sir Jeremy Fleming, ehemaliger Direktor des GCHQ. Diese angesehenen Fhrungskrfte bringen eine Flle von Fachwissen in den Bereichen Finanzen, Gesundheitswesen und nationale Sicherheit zu Quantexa.

Die Erweiterung des Beirats von Quantexa kommt zu einem entscheidenden Zeitpunkt fr das Unternehmen, nach dem Abschluss einer Serie–E–Finanzierungsrunde in Hhe von 129 Mio. USD unter der Leitung von GIC, mit der Quantexa in eine Elitegruppe britischer Technologieunternehmen eintritt, die den Status eines Einhorns erreicht haben. In diesem Jahr wurde auerdem bekannt gegeben, dass Quantexa in den nchsten drei Jahren ber 155 Mio. USD in die globale KI–Branche investieren wird, um Kunden dabei zu helfen, den Einsatz von KI zum Schutz, zur Optimierung und zum Wachstum ihrer Unternehmen voranzutreiben. Bis 2027 werden die weltweiten Investitionen von Quantexa in KI mehr als 250 Mio. USD erreichen.

Ralph Schlosstein, ehemaliger CEO von Evercore und ehemaliger President von BlackRock, bringt seine jahrzehntelange Erfahrung im Investmentbanking in den Beirat von Quantexa ein. In seiner herausragenden Karriere spielte er unter anderem eine strategische Rolle bei der Untersttzung des grten Vermgensverwaltungsunternehmens der Welt beim Brsengang. Der finanzielle Scharfsinn von Herrn Schlosstein wird eine entscheidende Rolle bei der Gestaltung von Unternehmensstrategie–Initiativen spielen.

Matthew Gould, ehemaliger CEO von NHSX, tritt dem Beirat von Quantexa bei, nachdem er zwischen 2010 und 2015 als britischer Botschafter in Israel ttig war. In dieser Zeit half Gould, den UK–Israel Technologies Hub ins Leben zu rufen "" eine Initiative, die in Tel Aviv luft, um Technologiepartnerschaften zwischen britischen und israelischen Unternehmen zu schmieden. In jngster Zeit hat Herr Gould seinen umfangreichen Hintergrund im Gesundheitswesen genutzt, um eine entscheidende Rolle bei der Beratung des NHS zu Initiativen whrend der Covid–19–Pandemie zu spielen. Bei NHSX war Gould fr die Nutzung von Daten und Technologien zur Verbesserung der Gesundheitsversorgung verantwortlich. Das fundierte Fachwissen von Herrn Gould wird Quantexa dabei helfen, die Volkswirtschaften und Branchen zu identifizieren, auf die man sich strategisch konzentrieren sollte, und Entscheidungen zur Geschftsstrategie zu treffen.

Sir Jeremy Fleming, ehemaliger Direktor des GCHQ und ehemaliger stellvertretender Leiter des MI5, tritt dem Beirat mit mehr als 30 Jahren Erfahrung in den Bereichen Geheimdienste und Technologie bei. Zu seinen umfangreichen Erfahrungen gehrt der Aufbau des National Cyber Security Centre, wo er sich dafr einsetzte, das Vereinigte Knigreich zum sichersten Ort zu machen, an dem man online leben und Geschfte machen kann. Sir Fleming setzt sich leidenschaftlich dafr ein, den Einsatz von Technologie durch den Staat transparenter zu machen, und wird die Fhigkeiten von Quantexa bei der Bewltigung neuer Bedrohungen und Chancen verbessern.

"Wir freuen uns, Ralph Schlosstein, Matthew Gould und Sir Jeremy Fleming in unserem Beirat willkommen zu heien", so Vishal Marria, CEO von Quantexa. "Ihr kollektives Fachwissen in den Bereichen Finanzen, Gesundheitswesen und nationale Sicherheit wird von unschtzbarem Wert sein, wenn wir weiterhin hochmoderne Decision Intelligence–Lsungen entwickeln, die den sich wandelnden Anforderungen des Marktes gerecht werden."

"Die KI–gesttzte Technologie von Quantexa ermglicht es seinen Kunden, ihre Unternehmen mit Effizienz und Transparenz zu schtzen, zu optimieren und zu vergrern", so Ralph Schlosstein, ehemaliger CEO von Evercore und ehemaliger President von BlackRock. "Ich glaube, dass Quantexa gut positioniert ist, um die kommenden Chancen zu nutzen und seinen Anteil an der aufstrebenden Kategorie Decision Intelligence zu erhhen. Ich freue mich darauf, das Fhrungsteam dabei zu untersttzen, seine organische und anorganische Wachstumsstrategie zu beschleunigen."

"Es ist eine aufregende Zeit fr mich, dem Beirat von Quantexa in dieser kritischen Wachstumsphase des Unternehmens beizutreten," so Matthew Gould. "Der innovative Ansatz von Quantexa, Kunden aus dem privaten und ffentlichen Sektor dabei zu helfen, Daten zu ihrem wertvollsten Hilfsmittel zu machen, revolutioniert die Entscheidungsfindung in zahlreichen Branchen. Ich freue mich darauf, mit dem talentierten Team von Quantexa zusammenzuarbeiten, um Daten zu verbinden und bessere Ergebnisse fr Unternehmen zu erzielen."

Sir Jeremy Fleming, ehemaliger Direktor des GCHQ, kommentierte dies wie folgt: "Ich bin begeistert, Teil eines Unternehmens zu sein, das an der Spitze der KI–Innovation steht. Ich freue mich darauf, meine Erfahrung mit den beeindruckenden Fhigkeiten von Quantexa zu kombinieren, die die Art und Weise, wie die Kunden von Quantexa Daten zum Schutz von Unternehmen und Brgern nutzen, weiter prgen werden."

Mit Hilfe seines Beirats widmet sich Quantexa weiterhin der Aufgabe, Unternehmen durch innovative Decision Intelligence–Lsungen in die Lage zu versetzen, verlssliche betriebliche Entscheidungen zu treffen. Mehr ber das Fhrungsteam von Quantexa finden Sie hier.

ber Quantexa"

Quantexa ist ein globales Unternehmen fr Daten– und Analysesoftware, das Pionierarbeit im Bereich Decision Intelligence leistet und Unternehmen in die Lage versetzt, vertrauenswrdige betriebliche Entscheidungen zu treffen, indem es Daten Bedeutung verleiht. Mit den neuesten Fortschritten in den Bereichen Big Data und KI deckt die Decision Intelligence–Plattform von Quantexa verborgene Risiken und neue Chancen auf, indem sie eine kontextbezogene, vernetzte Sicht auf interne und externe Daten an einem einzigen Ort bietet. Sie lst die grten Herausforderungen in den Bereichen Datenmanagement, KYC, Customer Intelligence, Finanzkriminalitt, Risiko, Betrug und Sicherheit whrend des gesamten Kundenlebenszyklus.

Die Quantexa Decision Intelligence–Plattform verbessert die operative Leistung mit ber 90 % mehr Genauigkeit und einer 60–mal schnelleren Auflsung des Analysemodells als herkmmliche Anstze. Quantexa wurde 2016 gegrndet und hat heute mehr als 650 Mitarbeiter und Tausende von Nutzern, die mit Milliarden von Transaktionen und Datenpunkten auf der ganzen Welt arbeiten. Das Unternehmen hat Niederlassungen in London, Dublin, New York, Boston, Washington DC, Toronto, den Vereinigten Arabischen Emiraten, Malaga, Amsterdam, Luxemburg, Brssel, Melbourne, Sydney und Singapur. Fr weitere Informationen folgen Sie uns auf LinkedIn.

Medienanfragen:
Kontakt: Stephanie Crisp, Associate Director and Media Strategist, Fight or Flight""
E–Mail: Quantexa@fightflight.co.uk""
"
Kontakt: Adam Jaffe, SVP of Corporate Marketing""
Tel.: +1 609 502 6889""
E–Mail: adamjaffe@quantexa.com""


GLOBENEWSWIRE (Distribution ID 1000841125)

Quantexa Appoints Industry Luminaries to its Advisory Board to Accelerate Growth Plans

LONDON, Sept. 22, 2023 (GLOBE NEWSWIRE) — Quantexa, the global leader in Decision Intelligence (DI) solutions for the private and public sectors, announced today that it has appointed three industry luminaries to its Advisory Board. These hires include Ralph Schlosstein, former CEO of Evercore and former President of BlackRock, Matthew Gould, former CEO of NHSX, and Sir Jeremy Fleming, Former Director of GCHQ. These distinguished leaders bring a wealth of expertise in finance, healthcare, and national security to Quantexa.

The expansion of Quantexa's Advisory Board comes at a pivotal time for the organization, following the completion of a $129 million Series E funding round, led by GIC, where Quantexa joined an elite group of UK tech companies reaching breakout unicorn status. It was also announced this year that Quantexa will invest over $155M in the global AI industry over the next three years to help clients advance the use of AI to protect, optimize, and grow their organizations. By 2027, Quantexa's total global investment in AI will reach more than $250M.

Ralph Schlosstein, former CEO of Evercore and former President of BlackRock, brings decades of experience in investment banking to Quantexa's Advisory Board. His distinguished career includes playing a strategic role in helping the world's largest asset management firm go public. Ralph's financial acumen will play a pivotal role in shaping corporate strategy initiatives.

Matthew Gould, former CEO of NHSX, joins Quantexa's Advisory Board, after serving as the British ambassador to Israel between 2010 and 2015, where Gould helped to launch the UK–Israel Technologies Hub "" an initiative run in Tel Aviv to forge technology partnerships between UK and Israeli companies. More recently, Matthew leveraged his extensive background in healthcare to play a pivotal role in advising NHS on initiatives throughout the Covid–19 pandemic. At NHSX, Gould has been responsible for harnessing the power of data and technology to improve healthcare delivery. Matthew's deep expertise will help Quantexa identify the economies and industries for strategic focus and make decisions on commercial strategy.

Sir Jeremy Fleming, Former Director of GCHQ, and former Deputy Head of MI5, joins the Advisory Board with more than 30 years of experience in intelligence and technology. His extensive background includes developing the National Cyber Security Centre, where he strived to make the UK the safest place to live and do business online. With a passion for making technology use in government more transparent, Sir Fleming will enhance Quantexa's capabilities in addressing emerging threats and opportunities.

“We are pleased to welcome Ralph Schlosstein, Matthew Gould, and Sir Jeremy Fleming to our Advisory Board,” said Vishal Marria, CEO of Quantexa. “Their collective expertise in finance, healthcare, and national security will be invaluable as we continue to develop cutting–edge decision intelligence solutions that address the evolving needs of the market.”

"Quantexa's AI–enabled technology allows its customers to protect, optimize, and grow their organizations with efficiency and transparency," said Ralph Schlosstein, former CEO of Evercore and former President of BlackRock. "I believe Quantexa is well–positioned to capture the opportunities ahead and increase its share of the emerging Decision Intelligence category. I am looking forward to supporting the executive team as they work to accelerate their organic and inorganic growth strategy."

“It's an exciting time for me to be joining Quantexa's Advisory Board, at this critical stage of growth for the company,” said Matthew Gould. “Quantexa's innovative approach to helping customers in the private and public sectors make data their most valuable utility is revolutionizing decision making across multiple industries. I look forward to working alongside the talented team at Quantexa to connect data and drive better outcomes for organizations."

Sir Jeremy Fleming, Former Director of GCHQ commented "I'm thrilled to be part of a company at the forefront of AI innovation. I look forward to combining my experience with Quantexa's impressive capabilities, which will continue to shape how their customers use data to protect businesses and citizens."

With the help of its Advisory Board, Quantexa remains dedicated to empowering organizations to make trusted operational decisions through innovative Decision Intelligence solutions. For more on Quantexa's Leadership team, visit here.

###

About Quantexa"

Quantexa is a global data and analytics software company pioneering Decision Intelligence that empowers organizations to make trusted operational decisions by making data meaningful. Using the latest advancements in big data and AI, Quantexa's Decision Intelligence platform uncovers hidden risk and new opportunities by providing a contextual, connected view of internal and external data in a single place. It solves major challenges across data management, KYC, customer intelligence, financial crime, risk, fraud, and security, throughout the customer lifecycle.

The Quantexa Decision Intelligence Platform enhances operational performance with over 90% more accuracy and 60 times faster analytical model resolution than traditional approaches. Founded in 2016, Quantexa now has more than 650 employees and thousands of users working with billions of transactions and data points across the world. The company has offices in London, Dublin, New York, Boston, Washington DC, Toronto, UAE, Malaga, Amsterdam, Luxembourg, Brussels, Melbourne, Sydney, and Singapore. For more information, follow us on LinkedIn.

Media Inquiries:
C: Stephanie Crisp, Associate Director and Media Strategist, Fight or Flight""
E: Quantexa@fightflight.co.uk""
"
C: Adam Jaffe, SVP of Corporate Marketing""
T: +1 609 502 6889""
E: adamjaffe@quantexa.com""


GLOBENEWSWIRE (Distribution ID 1000840648)

Impulse Dynamics Announces Leadership Changes

MARLTON, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) — Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure, announced new leadership appointments, including Jason Spees to Chief Executive Officer, Shlomi Nachman to Chairman of the Board, and John Liddicoat, M.D., as a member of the Board of Directors. Spees was recently President and Chief Commercial Officer at Impulse Dynamics and brings a depth of medical device industry experience from commercial leadership roles. Nachman most recently was the Company Group Chairman at Johnson & Johnson, overseeing the Cardiovascular and Specialty Solutions & Vision Group. Liddicoat most recently served as Executive Vice President and President of the Americas Region and Enterprise Technology & Innovation function at Medtronic.

"I am pleased to lead the Impulse Dynamics team, focusing on a strong commercialization strategy and our commitment to an ongoing pace of innovation to change the course of treatment for patients living with heart failure," said Spees. "We find ourselves in a unique position to capitalize on robust clinical data and a lineup of cutting–edge technologies, exemplified by the Integra–D trial featuring the groundbreaking single device that integrates our CCM technology with implantable cardioverter defibrillator (ICD) technology. I look forward to working closely with the board and the leadership team to optimize the company for its next phase of commercial acceleration."

"I am honored to join the board of an organization that has showcased substantial contributions to the advancement of heart failure treatment," said Shlomi Nachman. "Over 64 million people suffer from heart failure, and many of those treated are not experiencing the higher quality of life they deserve. With CCM therapy and its future product pipeline, we are in the exciting position of being able to help millions of these patients to feel better and lead fuller lives," Nachman added. "I'm looking forward to working with the leadership team and the board to ensure a direct path to ongoing innovation and commercial success."

"I've been watching Impulse Dynamics and its technology from the sidelines for many years, and I am excited to now be able to join the team," said Liddicoat. "I look forward to working with a strong leadership team to lead innovation–driven growth as we aim to enhance the standard of care for heart failure patients across the globe."

Jason Spees joined the company as President and Chief Commercial Officer in July 2021. He brings more than two decades of successful leadership roles in the medical device industry. Spees was most recently Senior Vice President of Sales and Marketing for Biotronik in the areas of cardiac rhythm management, cardiovascular intervention, peripheral vascular intervention, diagnostics, and digital health. Prior to Biotronik, Spees was the Chief Commercial Officer of Preventice Solutions, along with multiple leadership positions, including Vice President of Sales for Boston Scientific. He holds a B.S. in Operations Research and Engineering from the United States Air Force Academy and an M.A. in Public Management – Finance from the University of Maryland.

Shlomi Nachman was the Company Group Chairman of Cardiovascular and Specialty Solutions and Visions Group within Johnson & Johnson's Medical Devices sector. Nachman was a member of the Medical Devices Group Operating Committee, where he led a diverse portfolio of six medical device businesses, including Electrophysiology, Neurovascular Intervention, Ear, Nose & Throat, Breast Aesthetics, Optometry and Ophthalmology. Before that, Nachman had various roles with increased scope and responsibilities, including Worldwide President of Biosense Webster and Cordis. His career at Johnson & Johnson spanned over 27 years, comprising multiple leadership positions with a proven track record of success that has recognized the ability to drive growth, innovation, and architect business turnarounds. Additionally, Nachman has accrued deep knowledge in all aspects of medical devices, such as general management, strategy, L&A, finance, product development, operations, sales and marketing, and research and development. Nachman was born in Israel and holds a B.S. in Management and Economics from the Technion Institute, as well as a diploma in electrical engineering from the Amal Technical School.

John Liddicoat brings a history of transformational leadership focused on execution. He spent 16 years at Medtronic, driving the strategic direction and global operations of increasing size and scope, including the Structural Heart, Cardiac Rhythm, and Heart Failure businesses. In his most recent role as Executive Vice President and President of the Americas region and the Enterprise Innovation and Technology function, he was responsible for designing and implementing go–to–market strategies to deliver above–market growth across North and South America. Liddicoat graduated medical school from the University of Chicago, completed a residency in general and cardiothoracic surgery at Johns Hopkins Hospital, and served on the faculty of Harvard Medical School. An innovator and entrepreneur, he has also served as a consultant to venture capital firms and early–stage medical device companies.

About the Optimizer Integra CCM–D System and CCM Therapy

The Optimizer Integra CCM–D System is an investigational device that combines CCM therapy and ICD therapy into one device. This device is being used in an FDA–approved Investigational Device Exemption (IDE) study and is not available for sale in the United States.

Impulse Dynamics currently offers the Optimizer system that is FDA–approved and CE–marked. The Optimizer system delivers CCM therapy "" the company's proprietary technology "" to the heart. CCM therapy has been designed by Impulse Dynamics to improve the heart's contraction, allowing more oxygen–rich blood to be pushed out through the body. CCM therapy is indicated to improve the 6–minute hall walk, quality of life, and functional status of NYHA Class III heart failure patients who remain symptomatic despite guideline–directed medical therapy, are not indicated for CRT, and have a left ventricular ejection fraction ranging from 25 to 45 percent.

CCM therapy delivers non–excitatory electrical pulses from the implantable Optimizer device in a manner designed to improve heart contraction. CCM therapy sends unique electrical pulses to the heart cells during their absolute refractory period. Impulse Dynamics has completed numerous clinical studies, including several randomized controlled trials, and CCM therapy has been published in more than 120 peer–reviewed journal articles.

About Impulse Dynamics

Impulse Dynamics is dedicated to advancing the treatment of heart failure for patients and the healthcare providers who care for them. The company pioneered its proprietary CCM therapy, which uses the Optimizer technology platform to improve quality of life in heart failure patients. CCM therapy is delivered through the Optimizer system, which includes an IPG implanted in a minimally invasive procedure and approved for commercial use in the United States and 44 countries worldwide. More than 9,000 patients have received the therapy as part of clinical trials and real–world use, where it is proven to be safe and effective for heart failure patients with debilitating symptoms who otherwise have few effective options available to them. To learn more, visit www.ImpulseDynamics.com or follow the company on LinkedIn, Twitter, and Facebook.

Forward–Looking Statements

This press release contains forward–looking statements. All statements other than statements of historical facts contained in this press release are forward–looking statements. In some cases, you can identify forward–looking statements by terms such as ""may,'' ""will,'' ""should,'' ""expect,'' ""plan,'' ""anticipate,'' ""could,'' ""intend,'' ""target,'' ""project,'' ""contemplate,'' ""believe,'' ""estimate,'' ""predict,'' ""potential'' or ""continue'' or the negative of these terms or other similar expressions, although not all forward–looking statements contain these words. Forward–looking statements include, but are not limited to, statements concerning potential benefits of CCM therapy, and CCM therapy combined with an ICD delivered via a single device (CCM–D), and the absence of risks associated therewith; the ability for CCM therapy and our products to fill a significant unmet medical need for patients with heart failure; and the short–term and long–term benefits of the Optimizer Integra CCM–D System and CCM therapy in patients with heart failure, as well as to the physicians treating those patients. These forward–looking statements are based on management's current expectations and involve known and unknown risks and uncertainties that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward–looking statements. Other important factors that could cause actual results, performance or achievements to differ materially from those contemplated in this press release include, without limitation: the company's future research and development costs, capital requirements and the company's needs for additional financing; commercial success and market acceptance of CCM therapy; the company's ability to achieve and maintain adequate levels of coverage or reimbursement for Optimizer systems or any future products the company may seek to commercialize; competitive companies and technologies in the industry; the company's ability to expand its indications and develop and commercialize additional products and enhancements to its current products; the company's business model and strategic plans for its products, technologies and business, including its implementation thereof; the company's ability to expand, manage and maintain its direct sales and marketing organization; the company's ability to commercialize or obtain regulatory approvals for CCM therapy and its products, or the effect of delays in commercializing or obtaining regulatory approvals; FDA or other U.S. or foreign regulatory actions affecting us or the healthcare industry generally, including healthcare reform measures in the United States and international markets; the timing or likelihood of regulatory filings and approvals; and the company's ability to establish and maintain intellectual property protection for CCM therapy and products or avoid claims of infringement. The company does not undertake any obligation to update forward–looking statements and expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward–looking statements contained herein. These forward–looking statements should not be relied upon as representing the company's views as of any date subsequent to the date of this press release.

###


GLOBENEWSWIRE (Distribution ID 8924737)

Chief Sales Officer von AI-Media präsentiert Untertitelungsinnovation auf der kommenden IBC Broadcast-Messe

BROOKLYN, New York, Sept. 14, 2023 (GLOBE NEWSWIRE) — AI–Media, der fhrende Anbieter von technologiebasierten Lsungen fr Live–Untertitelung, Transkription und bersetzung, freut sich, seine Teilnahme an der IBC Show 2023 anzukndigen, die vom 15. bis 18. September in Amsterdam, Niederlande, stattfindet. Die Veranstaltung verspricht ein Zusammentreffen von Branchenexperten, Vordenkern und innovativen Unternehmen im Bereich der Rundfunk– und Medientechnologie zu werden.

Als weltweit fhrender Anbieter von Untertiteln fr die Rundfunk– und Fernsehbranche ist AI–Media stolz darauf, an dieser einflussreichen Veranstaltung teilzunehmen. Unser Chief Sales Officer, James Ward, wird unsere Delegation anfhren und unser Engagement fr Spitzenleistungen bei der Bereitstellung von Spitzenlsungen fr unsere Kunden und Partner vertreten.

James Ward, Chief Sales Officer von AI–Media, dazu:

"Wir freuen uns, dass wir erneut an der IBC teilnehmen knnen. Diese Messe ist eine auergewhnliche Plattform fr uns, um unsere neuesten Innovationen zu prsentieren und zu zeigen, wie wir die Grenzen des Machbaren in der Broadcast–Branche immer weiter verschieben. Wir freuen uns darauf, mit Branchenfhrern, Kunden und Partnern ins Gesprch zu kommen und unsere Vision fr die Zukunft des Broadcastings zu teilen."

AI–Media wird auf der Veranstaltung mehrere wichtige Broadcast–Lsungen vorstellen, deren Eckpfeiler unsere KI–gesttzte Lsung fr automatische Live–Untertitelung "" LEXI "" ist. LEXI liefert durchgngig Genauigkeitsraten von ber 98 %, erkennt Sprecherwechsel, nutzt KI, um sicherzustellen, dass die Untertitel den Bildschirminhalt nicht unterbrechen, und das alles zu einem Bruchteil der Kosten von menschlichen Untertiteln. Dieses innovative Tool revolutioniert die Untertitelung in Echtzeit und bietet eine kosteneffiziente Lsung, die von den weltweit fhrenden Rundfunkanstalten angenommen wird. AI–Media wird auf dem Stand Live–Demos durchfhren, um diese bahnbrechende Technologie in Aktion zu zeigen.

Das krzlich eingefhrte KI–gesttzte LEXI Captioning Tool Kit wird ebenfalls auf der IBC2023 vorgestellt und umfasst sechs Schlssellsungen, die jeweils fr unterschiedliche Untertitelungsanforderungen konzipiert sind. LEXI Tool Kit verndert die Erstellung von Inhalten und Untertiteln und bietet komplette End–to–End–Lsungen fr Medienunternehmen, Sendeanstalten, Veranstaltungsproduzenten, Bildungseinrichtungen und Content–Ersteller weltweit. Sender knnen die Komponenten des Toolkits je nach ihren geschftlichen Anforderungen kombinieren und auf Lsungen wie Untertitelung, bersetzung, Archivierung und Suche sowie Disaster Recovery zugreifen.

Mit der IP–Videoproduktion an der Spitze der Innovation in der Broadcasting–Landschaft knnen Sender auf AI–Media's ALTA Lsung fr ihre IP–kompatible Closed Captioning– und Untertitel–Encoding–Lsung zu suchen. ALTA untersttzt globale bertragungsstandards wie SMPTE–2110 und MPEG–TS–Eingnge und kann 2110–40, DVB–Untertitel, DVB–TTML, DVB–Teletext und SMPTE 2038 ausgeben. ALTA kann als eigenstndige virtuelle Maschine, als vorkonfiguriertes AMI oder als schlsselfertiger physischer Server bereitgestellt werden und fgt sich so in jeden Produktionsablauf ein. ALTA beherrscht nicht nur mhelos sechs Sprachen pro Instanz, sondern untersttzt auch die Einblendung von Werbehinweisen gem SCTE–35 und SCTE–104. Mit ALTA hilft AI–Media den Sendern, ihre IP–Videobertragungen auf ein neues Niveau der Reichweite und Zugnglichkeit zu heben. Ebenfalls am Stand erhltlich ist unser Angebot an SDI–Hardware–Encodern, einschlielich unseres Encoder Pro (HD492) 1 RU Caption Encoders "" mittlerweile der Broadcast–Standard fr SDI–Encoder.

Wir freuen uns auch, unseren Kunden einen ersten Einblick in unsere aktualisierte LEXI Translate–Lsung zu geben, die die nchste Stufe der sprachlichen Zugnglichkeit in unserem LEXI Tool Kit darstellt. Diese in Krze erscheinende Version zeichnet sich durch eine unbertroffene Genauigkeit bei der Echtzeitbersetzung aus und ermglicht es den Sendern, Inhalte an ein greres Publikum als je zuvor zu verbreiten.

Besuchen Sie AI–Media auf der IBC 2023, 15.–18. September, RAI Amsterdam Convention Centre, Stand Nr. 5.C31. Die Teilnehmer werden aufgefordert, einen Termin mit dem AI–Media–Team zu vereinbaren, um unser Angebot an Komplettlsungen fr die Untertitelung von Sendungen kennenzulernen.

ber AI–Media

Das 2003 in Australien gegrndete Technologieunternehmen AI–Media ist ein weltweit fhrender Anbieter von Lsungen fr Live– und aufgezeichnete Untertitelung, Transkription und bersetzung. Mit seiner KI–gesttzten automatischen Untertitelungslsung LEXI untersttzt das Unternehmen die weltweit fhrenden Rundfunkanstalten, Unternehmen und staatlichen Behrden bei der Gewhrleistung einer hochprzisen, sicheren und kosteneffektiven Untertitelung. LEXI–Untertitel werden ber den Untertitel–Encoder und das iCap Cloud–Netzwerk von AI–Media "" das weltweit grte und sicherste Netzwerk zur Bereitstellung von Untertiteln "" an Millionen von Bildschirmen weltweit geliefert. Weltweit liefert AI–Media monatlich ber 8 Millionen Minuten an Live– und aufgezeichneten Medien. AI–Media wird an der australischen Brse (ASX:AIM) gehandelt. Weitere Informationen finden Sie unter Ai–Media.tv.

Ein Foto zu dieser Ankndigung ist verfgbar unter : https://www.globenewswire.com/NewsRoom/AttachmentNg/976356bd–2ae1–4f56–89ed–437f9da454a2


GLOBENEWSWIRE (Distribution ID 8922473)

Le directeur des ventes chez AI-Media est ravi de présenter une innovation en matière de sous-titrage lors du prochain salon professionnel IBC sur la diffusion

BROOKLYN, État de New York, 14 sept. 2023 (GLOBE NEWSWIRE) — AI–Media, le chef de file des solutions de traduction, de transcription et de sous–titrage en direct s'axant sur la technologie, a le plaisir d'annoncer sa prsence au salon IBC 2023, qui doit avoir lieu du 15 au 18 septembre Amsterdam, aux Pays–Bas. L'vnement promet d'tre un rassemblement d'experts de l'industrie, de leaders d'opinion et d'entreprises innovantes dans le secteur de la diffusion et des technologies mdiatiques.

En tant que leader mondial du sous–titrage pour l'industrie de la diffusion, AI–Media est fire de faire partie de cet vnement d'une grande influence. Notre directeur des ventes, James Ward, dirigera notre dlgation et reprsentera notre engagement envers l'excellence dans la fourniture de solutions de pointe nos clients et partenaires.

James Ward, directeur des ventes d'AI–Media, a dclar :

Nous sommes ravis de faire une nouvelle fois partie du salon IBC. Ce salon professionnel est une plateforme exceptionnelle qui nous permet de prsenter nos dernires innovations et de dmontrer comment nous continuons repousser les frontires du possible dans l'industrie de la diffusion. Nous sommes impatients d'changer avec des leaders de l'industrie, des clients et des partenaires, et de partager notre vision de l'avenir de la diffusion.

AI–Media va prsenter plusieurs solutions de diffusion cls lors de l'vnement, LEXI tant la pierre angulaire de notre solution de sous–titrage automatique en direct optimise par l'IA. LEXI fournit systmatiquement des taux de prcision suprieurs 98 %, identifie les changements de locuteur, utilise l'IA pour garantir que les sous–titres n'interrompent pas le contenu l'cran, et tout cela pour une fraction du cot des sous–titres d'origine humaine. Cet outil innovant est en train de rvolutionner le sous–titrage en temps rel, apportant une solution rentable qui a t adopte par les plus grands diffuseurs du monde. AI–Media organisera des dmonstrations en direct sur le stand pour prsenter cette technologie rvolutionnaire en action.

Le Kit d'outils de sous–titrage LEXI optimis par l'IA rcemment lanc sera galement prsent lors du salon IBC2023, avec six solutions cls, chacune conue pour rpondre aux diffrents besoins du sous–titrage. Le Kit d'outils LEXI transforme la cration de contenu et le sous–titrage, en proposant des solutions de bout en bout compltes pour les socits de mdias, les diffuseurs, les producteurs d'vnements, les tablissements d'enseignement et les crateurs de contenu dans le monde entier. Les diffuseurs peuvent associer et assortir les lments du Kit d'outils en fonction de leurs besoins professionnels, en ayant accs des solutions qui comprennent le sous–titrage, la traduction, l'archivage et la recherche, ainsi que la reprise aprs sinistre.

Avec la production de vido IP l'avant–garde de l'innovation dans le paysage de la diffusion, les diffuseurs peuvent compter sur la solution ALTA d'AI–Media pour leur encodage de sous–titres compatibles IP. ALTA adhre aux normes de diffusion mondiales, notamment les entres SMPTE–2110 et MPEG–TS, et peut produire des sous–titres 2110–40, DVB, DVB TTML, DVB Teletext et SMPTE 2038. ALTA peut s'adapter n'importe quel flux de production car elle peut tre dploye en tant que machine virtuelle autonome, AMI prte l'emploi ou serveur physique cl en main. En plus de grer sans effort six langues par instance, ALTA prend galement en charge l'insertion de signaux publicitaires l'aide de marqueurs SCTE–35 et SCTE–104. Avec ALTA, AI–Media aide les diffuseurs lever leurs diffusions vido par IP vers de nouveaux sommets en termes de porte et d'accessibilit. Notre stand prsentera galement notre gamme d'encodeurs matriels SDI, notamment notre encodeur de sous–titres Encoder Pro (HD492) 1 RU, dsormais synonyme de norme de la diffusion pour les encodeurs SDI.

Nous sommes galement impatients de fournir aux clients un aperu anticip de notre solution LEXI Translate amliore, qui constitue le niveau suprieur d'accessibilit linguistique au sein de notre Kit d'outils LEXI. Cette version bientt disponible offre une prcision ingale de traduction en temps rel, ce qui permet aux diffuseurs de distribuer le contenu une audience plus vaste que jamais auparavant.

Rejoignez AI–Media lors du salon IBC 2023, du 15 au 18 septembre, au Centre de conventions et d'expositions RAI Amsterdam, stand n 5.C31. Les participants sont encourags rserver une rencontre avec l'quipe AI–Media qui leur fera dcouvrir notre gamme de solutions de sous–titrage pour la diffusion de bout en bout.

propos d'AI–Media

Fonde en Australie en 2003, la socit technologique AI–Media est un leader mondial des solutions de traduction, de transcription et de sous–titrage enregistrs et en direct. La socit aide les principaux diffuseurs, entreprises et organismes gouvernementaux du monde assurer des sous–titrages de haute prcision, scuriss et rentables via sa solution de sous–titrage automatique LEXI optimise par l'IA. Des sous–titres LEXI sont livrs sur des millions d'cran travers le monde grce la gamme d'encodeurs de sous–titrage d'AI–Media et son rseau iCap Cloud "" le rseau de livraison de sous–titres le plus grand et le plus scuris au monde. l'chelle mondiale, AI–Media livre plus de 8 millions de minutes de contenu multimdia en direct et enregistr chaque mois. AI–Media est cote la bourse australienne (ASX : AIM). Pour de plus amples informations, rendez–vous sur le site AI–Media.tv.

Une photo accompagnant cette annonce est disponible sur https://www.globenewswire.com/NewsRoom/AttachmentNg/976356bd–2ae1–4f56–89ed–437f9da454a2


GLOBENEWSWIRE (Distribution ID 8922473)